Melissa A. Moles

Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer.

R. Govindan, Michael S. Rooney, H. Sethi, 2022, Cancer cell.

A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer

Ying S. Ting, R. Govindan, Michael S. Rooney, 2020, Cell.